controlled human malaria infection
Alterations of blood coagulation in controlled human malaria infection
7
Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria naïve Dutch volunteers
8
Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose finding trial in two centres
11
Safety and efficacy after immunization with Plasmodium falciparum sporozoites in the controlled human malaria infection model
181
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
12
Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report
8
Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria naïve volunteers: effect of injection volume and dose on infectivity rates
13
Diagnosis and treatment based on quantitative PCR after controlled human malaria infection
7
A controlled human malaria infection model enabling evaluation of transmission blocking interventions
13
Increased sample volume and use of quantitative reverse transcription PCR can improve prediction of liver to blood inoculum size in controlled human malaria infection studies
9
Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis
17
Dichotomous miR expression and immune responses following primary blood-stage malaria
19
Use of gene expression studies to investigate the human immunological response to malaria infection
15
Cardiac complication after experimental human malaria infection: a case report
8
Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (Pv RON4)
10
A stochastic model for the probability of malaria extinction by mass drug administration
9
Monitoring mitochondrial inner membrane potential for detecting early changes in viability of bacterium-infected human bone marrow-derived mesenchymal stem cells
14
A model of Plasmodium vivax concealment based on Plasmodium cynomolgi infections in Macaca mulatta
11
Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases
5
Comparative Analysis on Malaria, Typhoid and Hepatitis B Virus Infections in Okigwe and Udo-Mbaise of IMO State, Nigeria
7